A Novel Linear B-spline Mixed Model for Repeated Measures (LB-MMRM) for Alzheimer’s Disease Clinical Study Data
Kun Jin, William R Chezem, Guoqiao Wang
0 citationsmedRxiv
William R Chezem
Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.
6Publications signalées
58Citations signalées
3Affiliations récentes
Institutions déclarées
Domaines associés
Pharmacological Receptor Mechanisms and EffectsDementia and Cognitive Impairment ResearchNicotinic Acetylcholine Receptors StudyAlzheimer's disease research and treatmentsEpilepsy research and treatment
Publications récentes
Precision Medicine in Alzheimer’s Disease (AD): Observed Efficacy Treatment Effects from Blarcamesine Clinical AD Trials
Marwan N. Sabbagh, Audrey Gabelle, Timo Grimmer, Luca Villa et autres
2 citationsAlzheimer s & Dementia
Phase IIb/III ATTENTION‐AD Study: Over Three Years of Continuous Treatment with Oral Blarcamesine Continues to Significantly Benefit Early Alzheimer’s Disease Patients
Marwan N. Sabbagh, Stephen Macfarlane, Audrey Gabelle, Timo Grimmer et autres
1 citationAlzheimer s & Dementia
A Patient‐Centric, Digital Multimodal Post‐Market Approval Continuous Monitoring of Drug Safety & Efficacy Platform for Blarcamesine
Audrey Gabelle, Marwan N. Sabbagh, Timo Grimmer, Luca Villa et autres
0 citationsAlzheimer s & Dementia
Oral Blarcamesine Phase IIb/III Trial Confirms Identified Precision Medicine Patient Population – Significant Broad Clinical and Quality of Life Improvements for Early Alzheimer’s Disease Patients
Stephen Macfarlane, Timo Grimmer, Ken Teo, Terence J. O’Brien et autres
1 citationmedRxiv
Blarcamesine for the treatment of Early Alzheimer's Disease: Results from the ANAVEX2-73-AD-004 Phase IIB/III trial
Stephen Macfarlane, Timo Grimmer, Ken Teo, Terence J. O’Brien et autres
54 citationsThe Journal of Prevention of Alzheimer s Disease
BNTIC News n’est pas le producteur de ces données. Recherche à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, ROR et la Banque mondiale, sans clé ; OpenAlex reste optionnel. Aucun service payant requis, aucune donnée externe enregistrée en base. Sources et limites.